Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hecker

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Scientific Reports|February 19, 2026
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacyKathrin Hessling, Caroline Brand, Christian Schwöppe, et al.
Blood|January 22, 2025
Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE2 signaling in NK cellsCharlotte Rothfuß, Tobias Baumann, Sainitin Donakonda, et al.
Blood|June 17, 2021
CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune diseaseJudith S Hecker, Luise Hartmann, Jennifer Rivière, et al.
Blood|July 10, 2025
Boosting CAR T-Cell Efficacy by Blocking Proteasomal Degradation of Membrane AntigensLeonie Rieger, Kilian Irlinger, Franziska Füchsl, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 13, 2024
Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma - A retrospective multicenter study of the Bavarian university hospitalsAnton Burkhard-Meier, Matthias Grube, Vindi Jurinovic, et al.
Annals of Surgical Oncology|May 14, 2025
Does Size Outweigh Number in Predicting Survival After Pulmonary Metastasectomy for Soft Tissue Sarcoma? Insights from a Retrospective Multicenter StudyAnton Burkhard-Meier, Matthias Grube, Vindi Jurinovic, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2023
Leukocytes carrying <i>Clonal Hematopoiesis of Indeterminate Potential</i> (CHIP) Mutations invade Human Atherosclerotic PlaquesMoritz von Scheidt, Sabine Bauer, Angela Ma, et al.
Eclinicalmedicine|June 19, 2026
Fertility management and outcomes after CAR T-cell therapy: an international survey from the Cellular Therapy and Immunobiology working party of the European Society for Blood and Marrow TransplantationGiorgio Orofino, Isabel Sánchez-Ortega, Juana Schwartz Mota, et al.
European Heart Journal|September 3, 2025
Clonal haematopoiesis of indeterminate potential and mortality in coronary artery diseaseMoritz von Scheidt, Shaunak S Adkar, Johannes Krefting, et al.
Journal of Cancer Research and Clinical Oncology|January 4, 2025
The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centersSiyer Roohani, Jolina Handtke, Kamal Hummedah, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Scientific Reports|February 19, 2026
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacyKathrin Hessling, Caroline Brand, Christian Schwöppe, et al.
Blood|January 22, 2025
Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE2 signaling in NK cellsCharlotte Rothfuß, Tobias Baumann, Sainitin Donakonda, et al.
Blood|June 17, 2021
CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune diseaseJudith S Hecker, Luise Hartmann, Jennifer Rivière, et al.
Blood|July 10, 2025
Boosting CAR T-Cell Efficacy by Blocking Proteasomal Degradation of Membrane AntigensLeonie Rieger, Kilian Irlinger, Franziska Füchsl, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 13, 2024
Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma - A retrospective multicenter study of the Bavarian university hospitalsAnton Burkhard-Meier, Matthias Grube, Vindi Jurinovic, et al.
Annals of Surgical Oncology|May 14, 2025
Does Size Outweigh Number in Predicting Survival After Pulmonary Metastasectomy for Soft Tissue Sarcoma? Insights from a Retrospective Multicenter StudyAnton Burkhard-Meier, Matthias Grube, Vindi Jurinovic, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2023
Leukocytes carrying <i>Clonal Hematopoiesis of Indeterminate Potential</i> (CHIP) Mutations invade Human Atherosclerotic PlaquesMoritz von Scheidt, Sabine Bauer, Angela Ma, et al.
Eclinicalmedicine|June 19, 2026
Fertility management and outcomes after CAR T-cell therapy: an international survey from the Cellular Therapy and Immunobiology working party of the European Society for Blood and Marrow TransplantationGiorgio Orofino, Isabel Sánchez-Ortega, Juana Schwartz Mota, et al.
European Heart Journal|September 3, 2025
Clonal haematopoiesis of indeterminate potential and mortality in coronary artery diseaseMoritz von Scheidt, Shaunak S Adkar, Johannes Krefting, et al.
Journal of Cancer Research and Clinical Oncology|January 4, 2025
The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centersSiyer Roohani, Jolina Handtke, Kamal Hummedah, et al.
Pageof 7